Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy.
出版信息
IARC Monogr Eval Carcinog Risks Hum. 2007;91:1-528.
Abstract
摘要
相似文献
1
Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy.
IARC Monogr Eval Carcinog Risks Hum. 2007;91:1-528.
2
Evaluation of the carcinogenic effects of estrogens, progestins and oral contraceptives on cervix, uterus and ovary of animals and man.
Arch Toxicol Suppl. 1979(2):59-84. doi: 10.1007/978-3-642-67265-1_5.
3
Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
Acta Endocrinol (Copenh). 1991;125 Suppl 1:13-26.
4
Sex steroids and breast cancer prevention.
J Natl Cancer Inst Monogr. 1994(16):139-47.
5
Oral oestrogen-progestagen contraceptives, menopausal treatment, and cancer.
Lancet Oncol. 2005 Oct;6(10):736; author reply 737. doi: 10.1016/S1470-2045(05)70365-X.
6
The menopause: benefits and risks of estrogen-progestogen replacement therapy.
Fertil Steril. 1982 Apr;37(4):457-74. doi: 10.1016/s0015-0282(16)46149-2.
7
The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.
Postgrad Med. 2017 Apr;129(3):340-351. doi: 10.1080/00325481.2017.1281083. Epub 2017 Jan 30.
8
The prevention of breast cancer through reduced ovarian steroid exposure.
Acta Oncol. 1992;31(2):167-74. doi: 10.3109/02841869209088898.
9
Estrogen-progestin oral contraceptive and nicotine exposure synergistically confers cardio-renoprotection in female Wistar rats.
Biomed Pharmacother. 2020 Sep;129:110387. doi: 10.1016/j.biopha.2020.110387. Epub 2020 Jun 12.
10
Carbohydrate metabolism in relation to hormonal replacement therapy.
Acta Obstet Gynecol Scand Suppl. 1981;106:51-6. doi: 10.3109/00016348209155331.
引用本文的文献
1
Incidence of de novo HPV infections in a previous HPV-negative group, related to use of different contraceptive methods: a retrospective cohort study.
Infect Agent Cancer. 2025 Aug 5;20(1):54. doi: 10.1186/s13027-025-00688-6.
2
The effect of hormone replacement therapy on cervical cancer risk in perimenopausal women: a systematic review and meta-analysis of observational studies.
Front Oncol. 2025 Jul 8;15:1621570. doi: 10.3389/fonc.2025.1621570. eCollection 2025.
3
Oral contraceptive use and risk of liver cancer: a population-based study, systematic review, and meta-analysis.
Lancet Oncol. 2025 Aug;26(8):1031-1042. doi: 10.1016/S1470-2045(25)00222-0. Epub 2025 Jul 3.
4
Understanding Susceptibility to Breast Cancer: From Risk Factors to Prevention Strategies.
Int J Mol Sci. 2025 Mar 25;26(7):2993. doi: 10.3390/ijms26072993.
5
Burden of cancer attributable to exogenous hormone use in Japan in 2015.
GHM Open. 2021 Dec 31;1(2):97-101. doi: 10.35772/ghmo.2021.01020.
6
Identification of Novel Progesterone Receptor (PR) Inhibitors () from Metabolites of Biotransformation Fungal: A Bioinformatics Approach.
Pharmaceuticals (Basel). 2025 Jan 21;18(2):136. doi: 10.3390/ph18020136.
7
Estimation of Population Attributable Fraction by Hormone and Reproductive Factors on Female Cancer in the Republic of Korea, 2015 to 2030.
Cancer Res Treat. 2024 Nov 19. doi: 10.4143/crt.2024.707.
8
Menopausal hormone therapy and incidence, mortality, and survival of breast cancer subtypes: a prospective cohort study.
Breast Cancer Res. 2024 Nov 4;26(1):151. doi: 10.1186/s13058-024-01897-4.
9
Genetic variants of glucose metabolism and exposure to smoking in African American breast cancer.
Endocr Relat Cancer. 2023 Mar 10;30(4). doi: 10.1530/ERC-22-0184. Print 2023 Apr 1.
10
Review of the literature on combined oral contraceptives and cancer.
Ecancermedicalscience. 2022 Jun 23;16:1416. doi: 10.3332/ecancer.2022.1416. eCollection 2022.
Zotero 插件